Inventor
JOAN MANNICK
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides22%
C12NMicroorganisms or enzymes22%
C07HSugars9%
C12YEnzymes4%
PatentTitleYear
12,252,518Methods of treating non-arteritic anterior ischemic optic neuropathy202512,214,037Treatment of cancer using humanized anti-BCMA chimeric antigen receptor202511,591,404Treatment of cancer using a CD123 chimeric antigen receptor202311,578,130Regulatable chimeric antigen receptor202311,459,390Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to NOVARTIS AG (4)· patent assignee history
2022–2025Patents assigned to UNIV PENNSYLVANIA (4)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to LIFE BIOSCIENCES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 4 | 2022–2025 |
| UNIV PENNSYLVANIA | 4 | 2022–2025 |
| LIFE BIOSCIENCES INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |